Clinical trials
Skin Neoplasms trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
26 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2007 | 1 |
| 2011 | 2 |
| 2013 | 2 |
| 2015 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 4 |
| 2024 | 2 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 8 |
| Completed | 7 |
| Recruiting | 5 |
| Active, not recruiting | 4 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 4 |
| Bristol-Myers Squibb | 3 |
| Novartis Pharmaceuticals | 3 |
| Regeneron Pharmaceuticals | 2 |
| Agenus Inc. | 1 |
| Alpha Tau Medical LTD. | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 1 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 1 |
| Genta Incorporated | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Skin Neoplasms | 26 |
| Melanoma | 19 |
| Head and Neck Neoplasms | 4 |
| Kidney Neoplasms | 4 |
| Neoplasms | 4 |
| Lung Neoplasms | 3 |
| Neoplasm Metastasis | 3 |
| Urinary Bladder Neoplasms | 3 |
| Basal Cell Carcinoma | 2 |
| Breast Neoplasms | 2 |
Trials
Showing 51 to 26 of 26. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.